MKI67 and neuroendocrine carcinoma: According to the recommendations of previous literature, patients were divided into four categories: Ki67<2%, 3% - 20%, 20% - 55%, and>55%, corresponding to NET G1, NET G2, NET G3 and some NEC, and highly malignant NEC patients with poor differentiation (3).